• The global Mycoplasma Testing market was valued at US$ 498 million in 2023 and is projected to reach US$ 1022 million by 2029, at a CAGR of 10.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
• This report aims to provide a comprehensive presentation of the global market for Mycoplasma Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycoplasma Testing. This report contains market size and forecasts of Mycoplasma Testing in global, including the following market information:
Email: help@24marketresearch.com
PCR
Enzymatic Methods
DNA Staining
Pharmaceuticals
• Charles River Laboratories International • Merck Kgaa • Lonza Group • Roche Diagnostics • SGS • Thermo Fisher Scientific
